Notice ID: 3dae5ab4c30f4fbd88a6d4eb53c41b0bAward NoticeAwarded
6505--Semaglutide (Ozempic) Inj Soln - GLP1A Glucagon-like Peptide 1 Receptor Agonists
Awarded on September 22, 2020. Full description on SAM.gov.
Awarded tounder 36E79720D0071 (source: SAM.gov award notice)• $598.2M
Overview
- Posted
- September 22, 2020
- Notice type
- Award Notice
- NAICS
- 325412: Pharmaceutical Preparation Manufacturing
- Agency
- Department of Veterans Affairs
Notice details
- Last updated
- Apr 29, 2026
- Award date
- Sep 22, 2020
- Award amount (SAM.gov award notice)
- $598.2M
Identifiers
- Solicitation number
- 36E79720R0055
- Notice ID
- 3dae5ab4c30f4fbd88a6d4eb53c41b0b
- Award number (PIID)
- 36E79720D0071
Description
PRE-SOLICITATION NOTICE: The VA National Acquisition Center intends to issue Request for Proposal (RFP) 36E79720R0055 for an unrestrictive procurement for once-weekly Glucagon-like peptide-1 receptor agonists (GLP1 agonist) with an FDA approved indication to reduce risk of major cardiovascular outcomes in adults with type 2 diabetes for the Department of Veterans Affairs (VA), Bureau of Prisons (BOP), and Indian Health Service (IHS). The VA will award one contract to the responsible offeror who will be able to provide an uninterrupted source of supply for the contracted items. The contract period will be for one year plus four pre-priced one-year option periods. The contract items will be distributed through the VA Pharmaceutical Prime Vendor Program. Offerors must state the exact name (name that appears on label) by which the drug will be supplied and have a unique NDC number. Solicitation # 36E79720R0055 will be electronically issued in commercial item format in accordance with FAR Part 12 on or about June 17, 2020, with a tentative closing date of July 2, 2020. The NAICS code for this procurement is 325412. Any future amendments and other miscellaneous documents will be available electronically for download at the following URL: http://www.fedbizopps.gov. No paper copies of the solicitation will be available, and no telephone requests for paper copies of the solicitation will be accepted. Interested offerors are advised to continuously check this URL for any changes to this solicitation. All responsible sources may submit an offer that if timely received, will be considered. The point of contact for this procurement is Teresa Hussain. Questions can be e-mailed to: Teresa.Hussain@va.gov. The estimated annual requirements are as follows: Item Description Size Estimated Annual Requirements 1a DULAGLUTIDE 0.75MG/0.5ML INJ,SOLN,PEN 4 PACK OR 1 383,700 1b SEMAGLUTIDE 0.5MG/0.375ML INJ,SOLN,PEN,1.5ML 1 PACK AND 2a DULAGLUTIDE 1.5MG/0.5ML INJ,SOLN,PEN 4 PACK OR 1 536,592 2b SEMAGLUTIDE 1MG/0.75ML INJ,SOLN,PEN,1.5ML 2 PACK
Award Overview
Award Number
36E79720D0071
Award Amount (SAM.gov award notice)
$598.2M
Award Date
Sep 22, 2020
Awardee
Awardee UEI
W72BJMJYBMN3
Original Solicitation
Notice ID: 3dae5ab4c30f4fbd88a6d4eb53c41b0b
Posted Date: Sep 22, 2020
Original Response Deadline: Not specified
More From This Vendor
Top 5 most recent
- —Signed Nov 5, 2026
- —Signed Sep 22, 2026
- —Signed Sep 1, 2026
- —Signed Aug 24, 2026
- —Signed Aug 24, 2026
Contacts
Documents
No documents available.
Lifecycle
Solicitation:
36E79720R0055- Pre-Solicitation
- Solicitation
- Awarded
This opportunity has been awarded.
- Pre-SolicitationJun 4, 2020
6505--GLP1A Glucagon-like Peptide 1 Receptor Agonists
- 3×SolicitationJun 26, 2020
6505--GLP1A Glucagon-like Peptide 1 Receptor Agonists
- AwardedCurrentSep 22, 2020
6505--Semaglutide (Ozempic) Inj Soln - GLP1A Glucagon-like Peptide 1 Receptor Agonists
Similar Opportunities
Title | Match | Phase | Deadline |
|---|---|---|---|
Additional Details
Solicitation Number
36E79720R0055
Archive Date
Nov 21, 2020
Office Address
HINES, IL, 60141